Volume : 08, Issue : 05, May – 2021
Title:
33.TO DETERMINE THE EFFECTIVENESS OF TAMSULOSIN ON DECREASING BLADDER OUTLET OBSTRUCTION BY EVALUATING ITS INDIRECT EFFECT ON BLADDER WEIGHT
Authors :
Dr. Farag Mohsen Saleh Abo Ali, Dr.Mohsin Mustafa Memon, Dr. M. Imran Malik, Dr. Sunil Kumar, Dr.Ahmad ullah, Dr.Shehzad Ali, Dr.Mehran Lashari, Dr.Junaid Habib Khan Prof.Murli Lal
Abstract :
Introduction: Urinary Bladder wall thickness and weight tend to be more in patients with urinary outlet obstruction caused by BPE (Benign Prostate Enlargement) in compensated early phase of the disease.
Aim: The purpose of the study was to determine the effectiveness of Tamsulosin on decreasing bladder outlet obstruction by evaluating its indirect effect on bladder weight.
Materials and Methods: The material in this study was composed of 63 patients, aged more then 45, with the present lower urinary tract symptoms (LUTS) caused by benign prostatic enlargement, who had not been treated for the previous 3 months. The inclusion criteria were also the value of (IPSS) IS ≥ 8 points, PMRV (post-void residual urine volume) <100ml, (PSA) <4nanogram/ml. The enrolled patients took Cap Tamsulosin 0.4 mg once daily and the evaluation parameters during the research were measured at time intervals of 4, 12 and 24 week. The parameters for evaluations was primary and secondary. Primary parameter was the (UEWB) ultrasonic estimated bladder weight, and the secondary were assessments of IPSS score, the quality-of-life determination (IPSS -QoL), and the amount of post-voided residual volume (PMRV), as well along with the determination of the number and strength of adverse reactions.
Results: At the time of the enrollment of the patients in the study, the arithmetic means of UEWB was 55g, PMRV was 43 ml, and IPSS of 20.97, and IPSS-QoL 5 points. After 24 weeks of management, the values were the following: the arithmetic mean of UEWB 30g, PMRV 6ml, IPSS 7 Point and the IPSS-Quality of life 2 point. The obtained outcomes of this study were processed by descriptive statistics (standard deviation and arithmetic mean) and analytical statistics by using Student’s t-test for dependent (paired) sample. The drug side effects (Dizziness 3%and ejaculation problems3% and headache 6%) were well tolerated and acceptable and did not lead to the discontinuation of the treatment.
Conclusion: We conclude that UEBW is a reliable, objective test for diagnosing BOO due to BPE. Moreover, it can also be used to monitor the effect of medical therapy for BPE via its indirect effect on detrusor hypertrophy.
Key words: Benign Prostatic Enlargement, Tamsulosin, Ultrasound Bladder Wall Thickness, Ultrasound Estimated Bladder Weight.
Cite This Article:
Please cite this article in press Farag Mohsen Saleh Abo Ali et al., To Determine The Effectiveness Of Tamsulosin On Decreasing Bladder Outlet Obstruction By Evaluating Its Indirect Effect On Bladder Weight.., Indo Am. J. P. Sci, 2021; 08(05).
Number of Downloads : 10
References:
1. F. Montorsi, D. Mercadante. Diagnosis of BPH and treatment of LUTS among GPs: a European Survey . Int J Clin 2013Feb; 67(2): 114-9.
2. John Reynard, Simon Brewster, Suzanne Bier. Oxford Hand Book of Urology .3rd ed. Oxford .Oxford Medical publisher;2013.p.71-126.
3. Paul Gleich,.Bladder Outlet Obstruction .Diagnosis and Medical Management. Consultant360 [Internet] 2012 Jan [cited 2012 jan;52(1)]. Available from: http://tinyurl.com/n5arj5l .
4. Housami F, Drake M, Abrams P.The use of ultrasound-estimated bladder weight in diagnosing bladder outlet obstruction and detrusor over activity in men with lower urinary tract symptoms .Indian J Urol 2009 Jan-Mar; 25(1): 105–109.
5. Özlem Tokgöz, Hüsnü Tokgöz, İlker Ünal, Umut Delibaş, Sema Yıldız, Nuray Voyvoda, Zuhal Erdem. Diagnostic values of detrusor wall thickness, postvoid residualurine, and prostate volume to evaluate lower urinary tract symptoms in men . Diagn Interv Radiol 2012; 18:277–281.
6. Alan J. Wein, Louis R. Kavoussi, Andrew C. Novick, Alan W. Partin,
Craig A. Peters,. Campbell-Walsh Urology.10th ed. Philadelphia
.Saunders Elsevier; 2011.p. 2597-2654
7. Milicevic S. Tamsulosin efficiency in treatment of benign prostatic hyperplasia evaluated by determining bladder weight. Med Arh. 2012 Dec; 66(6): 391-395.
8. Meigs JR,Mohr B,Barry MI. Risk factor for clinical benign prostatic hyperplasia in a community based population of healthy aging men.JClinEpidemiol 2001;54:935-944.
9. Berry SJ,Coffy DS, Wash PC, Ewing LL.The development of human benign prostatic hyperplasia with age .J Urol 1984 sep;132(3)474-9
10. Kortmann BBM, Floratos DL, Kiemeney LA et al. Urodynamic effects of alpha- adrenocapters blockers; a review of clinical trials. Urology 2003;62(1):1-9.
11. Kojima M, Inui E, OchiaiA, Naya Y, Ukimura O, Watanabe H. Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction. Urology. 1996; 47: 942.
12. Kojima M, Inui E, Ochiai A, Naya Y, Ukimura O, Watanabe H. Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement od bladder weight. J Urol. 1997; 157:476-479
13. Kojima M, Inui E, Ochiai A, Ukimura O, Watanabe H. Quantitative evaluation of estimated bladder weight (EWB) in men with infravesical obstruction using transabdominal sonography